Synergistic Effect of Alcohol Consumption and Body Mass on Serum Concentrations of Cytokeratin-18

Alcoholism: Clinical and Experimental Research

Volumn 35, Issue 12, 2011, Pages 2202-2208

  Gonzalez Quintela, Arturo ^a   Tomé, Santiago ^a   Fernandez Merino, Carmen ^b   Rey, Jesus ^b   Meijide, Luis ^b   Gude, Francisco ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b Primary Care Unit   (Spain)

Author keywords

Alcohol; Apoptosis; Cytokeratin 18; Metabolic Syndrome; Obesity

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ASPARTATE AMINOTRANSFERASE; CYTOKERATIN 18; GAMMA GLUTAMYLTRANSFERASE; TISSUE POLYPEPTIDE ANTIGEN;

ABDOMINAL OBESITY; ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ARTICLE; BODY MASS; DRINKING BEHAVIOR; FEMALE; HIGH RISK BEHAVIOR; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; BIOLOGICAL MARKERS; BODY MASS INDEX; FEMALE; HUMANS; KERATIN-18; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; YOUNG ADULT;

EID: 80053619596     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2011.01570.x     Document Type: Article

References (64)

1. Alatalo PI, Koivisto HM, Hietala JP, Puukka KS, Bloigu R, Niemela OJ (2008) Effect of moderate alcohol consumption on liver enzymes increases with increasing body mass index. Am J Clin Nutr 88:1097-1103.
2. Ashworth M, Gerada C (1997) ABC of mental health. Addiction and dependence II: Alcohol. BMJ 315:358-360.
3. ATP-III (Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults) (2001) Executive Summary of Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486-2497.
4. Bantel H, Lügering A, Heidemann J, Volkmann X, Poremba C, Strassburg CP, Manns MP, Schulze-Osthoff K (2004) Detection of apoptotic caspase activation in sera from patients with chronic hepatitis HCV infection is associated with fibrotic liver injury. Hepatology 40:1078-1082.
5. Barak V, Goike H, Panaretakis KW, Einarsson R (2004) Clinical utility of cytokeratins as tumor markers. Clin Biochem 37:529-540.
6. Bonfrer JM, Groeneveld EM, Korse CM, van Dalen A, Oomen LC, Ivanyi D (1994) Monoclonal antibody M3 used in tissue polypeptide-specific antigen assay for the quantification of tissue polypeptide antigen recognizes keratin 18. Tumour Biol 15:210-222.
7. Botto LD, Khoury MJ (2001) Commentary: facing the challenge of gene-environment interaction: the two-by-four table and beyond. Am J Epidemiol 153:1016-1020.
8. Caldwell S, Argo C (2010) The natural history of non-alcoholic fatty liver disease. Dig Dis 28:162-168.
9. Day CP (2001) Apoptosis in alcoholic hepatitis: a novel therapeutic target? J Hepatol 34:330-333.
10. Day CP (2006) Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease. Liver Int 26:1021-1028.
11. Diehl AM (2004) Obesity and alcoholic liver disease. Alcohol 34:81-87.
12. Diehl AM, Goodman Z, Ishak KG (1988) Alcohol-like liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 95:1056-1062.
13. Einarsson R, Lei JD, Ullrich A, Van Dalen A (1999) Performance characteristics of Immulite TPS: a comparison with TPS IRMA. Anticancer Res 19:2743-2747.
14. Einarsson R, Rydlander L (1997) Tissue polypeptide specific antigen (TPS) detects a specific epitope structure on human cytokeratin. Anticancer Res 17:3121-3124.
15. Feldstein AE, Gores GJ (2005) Apoptosis in alcoholic and nonalcoholic steatohepatitis. Front Biosci 10:3093-3099.
16. Gonzalez-Quintela A, Abdulkader I, Campos J, Fernandez-Hernandez L, Lojo S (2009) Serum levels of keratin-18 fragments [tissue polypeptide-specific antigen (TPS)] are correlated with hepatocyte apoptosis in alcoholic hepatitis. Dig Dis Sci 54:648-653.
17. Gonzalez-Quintela A, Abdulkader I, Otero E, Freire MA, Tomé S (2010) Relationship between serum concentrations of keratin-18 and apoptosis in chronic hepatitis C. Clin Chem Lab Med 48:897-899.
18. Gonzalez-Quintela A, García J, Campos J, Perez LF, Alende MR, Otero E, Abdulkader I, Tome S (2006b) Serum cytokeratins in alcoholic liver disease: contrasting levels of cytokeratin-18 and cytokeratin-19. Alcohol 38:45-49.
19. Gonzalez-Quintela A, Gude F, Boquete O, Rey J, Meijide LM, Suarez F, Fernández-Merino MC, Pérez LF, Vidal C (2003) Association of alcohol consumption with total serum immunoglobulin E levels and allergic sensitization in an adult population-based survey. Clin Exp Allergy 33:199-205.
20. Gonzalez-Quintela A, Lojo S, Otero E, Perez LF (2007) Keratin-18 as a marker of steatohepatitis. Hepatology 45:545.
21. Gonzalez-Quintela A, Mallo N, Mella C, Campos J, Perez LF, Lopez-Rodriguez R, Tome S, Otero E (2006a) Serum levels of cytokeratin-18 (tissue polypeptide-specific antigen) in liver diseases. Liver Int 26:1217-1224.
22. Gonzalez-Quintela A, Mella C, Abdulkader I, Perez LF, Campos J, Otero E, Forteza J (2004) Serum levels of tissue polypeptide specific antigen are correlated with hepatocyte cytokeratin expression in alcoholic liver disease. Alcohol Clin Exp Res 28:1413-1418.
23. Gonzalez-Quintela A, Mella C, Perez LF, Abdulkader I, Caparrini AM, Lojo S (2000) Increased serum TPS (tissue polypeptide specific antigen) in alcoholics. A possible marker of alcoholic hepatitis. Alcohol Clin Exp Res 24:1222-1226.
24. Greystoke A, Cummings J, Ward T, Simpson K, Renehan A, Butt F, Moore D, Gietema J, Blackhall F, Ranson M, Hughes A, Dive C (2008) Optimisation of circulating biomarkers of cell death for routine clinical use. Ann Oncol 19:990-995.
25. Gual A, Martos AR, Lligoña A, Llopis JJ (1999) Does the concept of a standard drink apply to viticultural societies? Alcohol Alcohol 34:153-160.
26. Haren MT, Li M, Petkov J, McDermott RA (2010) Alcohol, metabolic risk and elevated serum gamma-glutamyl transferase (GGT) in Indigenous Australians. BMC Public Health 10:454.
27. Hart CL, Morrison DS, Batty GD, Mitchell RJ, Davey Smith G (2010) Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies. BMJ 340:c1240.
28. Kloner RA, Rezkalla SH (2007) To drink or not to drink? That is the question. Circulation 116:1306-1317.
29. Kramer G, Erdal H, Mertens HJ, Nap M, Mauermann J, Steiner G, Marberger M, Bivén K, Shoshan MC, Linder S (2004) Differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18. Cancer Res 64:1751-1756.
30. Ku NO, Strnad P, Zhong BH, Tao GZ, Omary MB (2007) Keratins let liver live: mutations predispose to liver disease and crosslinking generates Mallory-Denk bodies. Hepatology 46:1639-1649.
31. Leers MP, Kölgen W, Björklund V, Bergman T, Tribbick G, Persson B, Björklund P, Ramaekers FC, Björklund B, Nap M, Jörnvall H, Schutte B (1999) Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J Pathol 187:567-572.
32. Linder S (2007) Cytokeratin markers come of age. Tumor Biol 28:189-195.
33. Loomba R, Bettencourt R, Barrett-Connor E (2009) Synergistic association between alcohol intake and body mass index with serum alanine and aspartate aminotransferase levels in older adults: the Rancho Bernardo Study. Aliment Pharmacol Ther 30:1137-1149.
34. Malhi H, Gores GJ (2008) Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease. Semin Liver Dis 28:360-369.
35. Marrero JA, Fontana RJ, Fu S, Conjeevaram HS, Su GL, Lok AS (2005) Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol 42:218-224.
36. Moraglio D, Pagano M, Galeazzi D, Arnelli A, Bertero L (1994) Tissue polypeptide specific antigen (TPS) in liver disease. Clin Chim Acta 224:209-214.
37. Natori S, Rust C, Stadheim LM, Srinivasan A, Burgart LJ, Gores GJ (2001) Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis. J Hepatol 34:248-253.
38. Naveau S, Cassard-Doulcier AM, Njiké-Nakseu M, Bouchet-Delbos L, Barri-Ova N, Boujedidi H, Dauvois B, Balian A, Maitre S, Prévot S, Dagher I, Agostini H, Grangeot-Keros L, Emilie D, Perlemuter G (2010) Harmful effect of adipose tissue on liver lesions in patients with alcoholic liver disease. J Hepatol 52:895-902.
39. Naveau S, Giraud V, Borlotto E, Aubert A, Capron F, Chaput J (1997) Excess weight risk factor for alcoholic liver disease. Hepatology 25:108-111.
40. Niemela O (2007) Biomarkers in alcoholism. Clin Chim Acta 377:39-49.
41. Omary MB, Ku NO, Toivola DM (2002) Keratins: guardians of the liver. Hepatology 35:251-257.
42. Ouyang X, Cirillo P, Sautin Y, McCall S, Bruchette JL, Diehl AM, Johnson RJ, Abdelmalek MF (2008) Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol 48:993-999.
43. Papatheodoridis GV, Hadziyannis E, Tsochatzis E, Chrysanthos N, Georgiou A, Kafiri G, Manolakopoulos S, Tiniakos DG, Giannousis I, Manesis EK, Archimandritis AJ (2008) Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection. Gut 57:500-506.
44. Raynard B, Balian A, Fallik D, Capron F, Bedossa P, Chaput JC, Naveau S (2002) Risk factors of fibrosis in alcohol-induced liver disease. Hepatology 35:635-638.
45. Rodriguez J, Varela-Calviño R, Garrido Outeiriño M, Rodríguez-Segade S, Camiña F (2007) Tissue-polypeptide-specific antigen levels in diabetic patients with normal and pathological biochemical profiles. Clin Biochem 40:278-281.
46. Rothman KJ (1976) The estimation of synergy or antagonism. Am J Epidemiol 103:506-511.
47. Schattenberg JM, Galle PR, Schuchmann M (2006) Apoptosis in liver disease. Liver Int 26:904-911.
48. Schutte B, Henfling M, Kölgen W, Bouman M, Meex S, Leers MP, Nap M, Björklund V, Björklund P, Björklund B, Lane EB, Omary MB, Jörnvall H, Ramaekers FC (2004) Keratin 8/18 breakdown and reorganization during apoptosis. Exp Cell Res 297:11-26.
49. Schweizer J, Bowden PE, Coulombe PA, Langbein L, Lane EB, Magin TM, Maltais L, Omary MB, Parry DA, Rogers MA, Wright MW (2006) New consensus nomenclature for mammalian keratins. J Cell Biol 174:169-174.
50. Sheard MA, Vojtesek B, Simickova M, Valik D (2002) Release of cytokeratin-18 and -19 fragments (TPS and CYFRA 21-1) into the extracellular space during apoptosis. J Cell Biochem 85:670-677.
51. Shen Z, Li Y, Yu C, Shen Y, Xu L, Xu C, Xu G (2010) A cohort study of the effect of alcohol consumption and obesity on serum liver enzyme levels. Eur J Gastroenterol Hepatol 2010:22.
52. Skrondal A (2003) Interaction as departure from additivity in case-control studies: a cautionary note. Am J Epidemiol 158:251-258.
53. Strnad P, Stumptner C, Zatloukal K, Denk H (2008) Intermediate filament cytoskeleton of the liver in health and disease. Histochem Cell Biol 129:735-749.
54. Suter PM (2005) Is alcohol consumption a risk factor for weight gain and obesity? Crit Rev Clin Lab Sci 42:197-227.
55. Syn WK, Teaberry V, Choi SS, Diehl AM (2009) Similarities and differences in the pathogenesis of alcoholic and nonalcoholic steatohepatitis. Semin Liver Dis 29:200-210.
56. Szklo M, Nieto FJ (2000) Epidemiology: Beyond the Basics. Aspen Publishers, Gaithersburg, MD.
57. Tarantino G, Conca P, Coppola A, Vecchione R, Di Minno G (2007) Serum concentrations of the tissue polypeptide specific antigen in patients suffering from non-alcoholic steatohepatitis. Eur J Clin Invest 37:48-53.
58. Tarantino G, Mazzarella C, Tarantino M, Di Minno MN, Conca P (2009) Could high levels of tissue polypeptide specific antigen, a marker of apoptosis detected in nonalcoholic steatohepatitis, improve after weight loss? Dis Markers 26:55-63.
59. Tremblay A, Wouters E, Wenker M, St-Pierre S, Bouchard C, Despres J (1995) Alcohol and a high-fat diet: a combination favoring overfeeding. Am J Clin Nutr 62:639-644.
60. Ueno T, Toi M, Linder S (2005) Detection of epithelial cell death in the body by cytokeratin 18 measurement. Biomed Pharmacother 59(Suppl 2):S359-S362.
61. Wieckowska A, Zein NN, Yerian LM, Lopez AR, McCullough AJ, Feldstein AE (2006) In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology 44:27-33.
62. Yagmur E, Trautwein C, Leers MP, Gressner AM, Tacke F (2007) Elevated apoptosis-associated cytokeratin 18 fragments (CK18Asp386) in serum of patients with chronic liver diseases indicate hepatic and biliary inflammation. Clin Biochem 40:651-655.
63. Yilmaz Y, Dolar E, Ulukaya E, Akgoz S, Keskin M, Kiyici M, Aker S, Yilmaztepe A, Gurel S, Gulten M, Nak SG (2007) Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis. World J Gastroenterol 13:837-844.
64. Zatloukal K, Stumptner C, Fuchsbichler A, Fickert P, Lackner C, Trauner M, Denk H (2004) The keratin cytoskeleton in liver diseases. J Pathol 204:367-376.